This week hosts Mark Masselli and Margaret Flinter speak with renowned virus expert Dr. William Haseltine who has ‘grave concerns’ about Merck’s oral COVID drug Malnupiravir, which recently won narrow approval from the FDA advisory panel. He says the drug unleashes ‘dangerous’ mutations that could evolve the virus beyond control. He’s also urging extreme caution as the highly infectious omicron variant is sweeping across the US, saying it could be as deadly as the delta variant and that boosters may offer only limited protection of 3 months. Dr Haseltine, who developed the Anthrax vaccine and is President of ACCESS Health International, says public health protocols of masking, rapid testing and social distancing should be put back in place during this next surge.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast February 27, 2025. How reliable is the current research into the cause of…
Dr. Louis Sullivan walked the halls of Congress and testified before committees when he was…
Originally broadcast February 13, 2025 $4.95 — that’s the record high price of a dozen…
Originally broadcast February 6, 2025 Artificial intelligence is revolutionizing health care—but how do we ensure…
Originally broadcast January 30, 2025. Noted healthcare leader Dr. Sachin Jain has been publicly releasing…
Originally broadcast January 23, 2025 President Trump’s first days in office have resulted in a…